Skip to main content
. 2022 Apr 4;11(7):1215. doi: 10.3390/cells11071215

Figure 4.

Figure 4

Cell viability of 12 patient-derived glioblastoma cell lines treated with TMZ (A), RT (B) or TMZ + RT (C). Cell lines were treated with a clinically relevant dose of TMZ (35 µM) and/or RT (2 Gy), grown as adherent cultures for 7 days before being assessed for cell viability with an MTT assay. Data points represent the mean and SEM of three biological replicates over three independent experiments.